Departamento de Sistemas Biológicos, División de Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana-Xochimilco (UAM-X), Ciudad de México 04960, Mexico.
Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias-Pediatría, IMSS, Ciudad de México 06720, Mexico.
Molecules. 2017 Oct 31;22(11):1864. doi: 10.3390/molecules22111864.
Indazole is considered a very important scaffold in medicinal chemistry. It is commonly found in compounds with diverse biological activities, e.g., antimicrobial and anti-inflammatory agents. Considering that infectious diseases are associated to an inflammatory response, we designed a set of 2-indazole derivatives by hybridization of cyclic systems commonly found in antimicrobial and anti-inflammatory compounds. The derivatives were synthesized and tested against selected intestinal and vaginal pathogens, including the protozoa , , and ; the bacteria and serovar Typhi; and the yeasts and . Biological evaluations revealed that synthesized compounds have antiprotozoal activity and, in most cases, are more potent than the reference drug metronidazole, e.g., compound is 12.8 times more active than metronidazole against . Furthermore, two 2,3-diphenyl-2-indazole derivatives ( and ) showed in vitro growth inhibition against and . In addition to their antimicrobial activity, the anti-inflammatory potential for selected compounds was evaluated in silico and in vitro against human cyclooxygenase-2 (COX-2). The results showed that compounds , , , and display in vitro inhibitory activity against COX-2, whereas docking calculations suggest a similar binding mode as compared to rofecoxib, the crystallographic reference.
吲唑被认为是药物化学中非常重要的一个支架。它通常存在于具有多种生物活性的化合物中,例如抗菌和抗炎剂。考虑到传染病与炎症反应有关,我们通过将抗菌和抗炎化合物中常见的环状系统杂交,设计了一系列 2-吲唑衍生物。合成了这些衍生物,并对选定的肠道和阴道病原体进行了测试,包括原生动物、和、细菌和血清型伤寒杆菌以及酵母和。生物评价结果表明,合成的化合物具有抗原生动物活性,并且在大多数情况下比参考药物甲硝唑更有效,例如,化合物对的活性比甲硝唑高 12.8 倍。此外,两种 2,3-二苯基-2-吲唑衍生物(和)对和显示体外生长抑制作用。除了它们的抗菌活性外,还通过计算机模拟和体外试验评估了选定化合物对人环氧化酶-2(COX-2)的抗炎潜力。结果表明,化合物、、、和在体外对 COX-2 具有抑制活性,而对接计算表明其与罗非昔布(晶态参考药物)具有相似的结合模式。